M. D. DeFuria
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Urology top 5%
- Urological Disorders and Treatments
Papers in
- Surgery 6
- Bladder and Urothelial Cancer Treatments 6
- Urinary and Genital Oncology Studies 3
-
- Polyamine Metabolism and Applications 3
- Co-authors
- K. E. Price (2 shared papers)T. A. Pursiano (2 shared papers)Mark S. Soloway (5 shared papers)Stanley T. Crooke (3 shared papers)William M. Murphy (2 shared papers)George R. Prout (2 shared papers)Barry N. Nocks (1 shared paper)James Daly (1 shared paper)
- Journals
- The Journal of Urology (2 papers)Cancer (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)The Journal of Infectious Diseases (1 paper)PubMed (2 papers)
- Partner nations
- United StatesGermany
In The Last Decade
M. D. DeFuria
8 papers receiving 292 citations
Peers
Comparison fields: 5 of 57
- Molecular Medicine 105
- Urology 60
- Pharmacology 105
- Applied Microbiology and Biotechnology 8
- Surgery 164
Countries citing papers authored by M. D. DeFuria
This map shows the geographic impact of M. D. DeFuria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. D. DeFuria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. D. DeFuria more than expected).
Fields of papers citing papers by M. D. DeFuria
This network shows the impact of papers produced by M. D. DeFuria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. D. DeFuria. The network helps show where M. D. DeFuria may publish in the future.
Co-authors
The 22 scholars most cited alongside M. D. DeFuria, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1974 | 92 | |
| 2 | 1976 | 77 | |
| 3 | 1981 | 65 | |
| 4 | 1984 | 37 | |
| 5 | 1982 | 35 | |
| 6 | Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report. | 1980 | 28 |
| 7 | Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms. | 1980 | 9 |
| 8 | Intravesical mitomycin C in superficial bladder cancer | 1981 | 1 |
About M. D. DeFuria
M. D. DeFuria is a scholar working on Surgery, Molecular Biology, Pharmacology, Molecular Medicine and Infectious Diseases, having authored 8 papers that have together received 344 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (6 papers), Urinary and Genital Oncology Studies (3 papers), Polyamine Metabolism and Applications (3 papers), Antibiotic Resistance in Bacteria (2 papers), Antibiotics Pharmacokinetics and Efficacy (1 paper), Urinary Bladder and Prostate Research (1 paper), Cancer Research and Treatments (1 paper) and Probiotics and Fermented Foods (1 paper). The work is most often cited by research in Molecular Medicine (105 citations), Urology (60 citations), Pharmacology (105 citations), Applied Microbiology and Biotechnology (8 citations) and Surgery (164 citations). M. D. DeFuria has collaborated with scholars based in United States and Germany. Frequent co-authors include K. E. Price, T. A. Pursiano, Mark S. Soloway, Stanley T. Crooke, William M. Murphy, George R. Prout, Barry N. Nocks, James Daly, Pamela P. Griffin and Lee Roy Morgan. Their work appears in journals such as The Journal of Urology, Cancer, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.